TY - JOUR
T1 - Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism
AU - Reyes, Edgar Julián
AU - Ruiz-Talero, Paula
AU - Arenas, Mayra Alejandra
AU - Hernández-Flórez, Catalina
AU - Muñoz, Oscar M.
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/12
Y1 - 2023/12
N2 - OBJECTIVE: To identify factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer who present with venous thromboembolic disease (VTE).METHODS: In this prospective cohort, in-hospital and outpatient survival rates up to 180 days were analyzed using Kaplan-Meier curves. Cox regression was used to identify factors associated with different survival functions.RESULTS: One hundred patients were analyzed (median age, 67.5 years; 75% with Charlson index of <10; 69% with Eastern Cooperative Oncology Group (ECOG) score of 3-4). In-hospital mortality was 18%, and the median time from admission to death was 11 days (interquartile range, 1-61 days). Factors significantly associated with in-hospital mortality were the ECOG score and thrombocytopenia. The 180-day mortality rate was 52%, with deaths mainly occurring in the first 90 days since VTE diagnosis. Additional factors significantly associated with outpatient mortality included male sex and neoplasms with a high risk of thrombosis (lung, pancreas, stomach, uterus, bladder, and kidney neoplasms).CONCLUSION: Patients with stage IV cancer and acute VTE have short survival. Poor prognostic factors are thrombocytopenia, the ECOG score, and certain types of cancer. These results may help physicians individualize decisions regarding initiation and continuation of anticoagulant therapy.
AB - OBJECTIVE: To identify factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer who present with venous thromboembolic disease (VTE).METHODS: In this prospective cohort, in-hospital and outpatient survival rates up to 180 days were analyzed using Kaplan-Meier curves. Cox regression was used to identify factors associated with different survival functions.RESULTS: One hundred patients were analyzed (median age, 67.5 years; 75% with Charlson index of <10; 69% with Eastern Cooperative Oncology Group (ECOG) score of 3-4). In-hospital mortality was 18%, and the median time from admission to death was 11 days (interquartile range, 1-61 days). Factors significantly associated with in-hospital mortality were the ECOG score and thrombocytopenia. The 180-day mortality rate was 52%, with deaths mainly occurring in the first 90 days since VTE diagnosis. Additional factors significantly associated with outpatient mortality included male sex and neoplasms with a high risk of thrombosis (lung, pancreas, stomach, uterus, bladder, and kidney neoplasms).CONCLUSION: Patients with stage IV cancer and acute VTE have short survival. Poor prognostic factors are thrombocytopenia, the ECOG score, and certain types of cancer. These results may help physicians individualize decisions regarding initiation and continuation of anticoagulant therapy.
KW - Female
KW - Humans
KW - Male
KW - Aged
KW - Venous Thromboembolism/complications
KW - Outpatients
KW - Prospective Studies
KW - Neoplasms/complications
KW - Hospitals
KW - Thrombocytopenia/complications
KW - Risk Factors
KW - Anticoagulants/therapeutic use
KW - Retrospective Studies
UR - http://www.scopus.com/inward/record.url?scp=85180920209&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/bd6934cd-9aab-3036-8d13-53ea12394540/
U2 - 10.1177/03000605231219170
DO - 10.1177/03000605231219170
M3 - Article
C2 - 38147642
AN - SCOPUS:85180920209
SN - 0300-0605
VL - 51
JO - Journal of International Medical Research
JF - Journal of International Medical Research
IS - 12
ER -